High dietary fructose consumption is a recognized risk factor for metabolic dysfunction-associated steatotic liver disease (MASLD), but the clinical relevance of fasting fructose levels remains unexplored. This study investigated gut microbiota and hepatic transcriptional alterations associated with fasting fructose levels and their potential link to MASLD. We analyzed data from a subset of 49 morbidly obese individuals enrolled in the prospective BARIA cohort.
Fasting plasma fructose is associated with postprandial ethanol levels and mitochondrial dysfunction: linking fasting fructose to MASLD
calendar_today
October 30, 2026
person
Westerbeke, F. H. M., Attaye, I., Meijnikman, A. S., Farras Sole, N., Kovynev, A., Akinrimisi, O. I., Verheij, J., Doukas, M., van de Laar, A., Franken, R., Rios-Morales, M., Nieuwdorp, M.
domain
medrxiv